The New England journal of medicine | 2019
Personalized Medicine for Primary Treatment of Serous Ovarian Cancer.
Abstract
The introduction of “personalized medicine” has spurred major changes in oncology, but success has been spread unevenly across the spectrum of solid tumors. Although prognoses for adenocarcinoma of...